Lincoln Pharmaceuticals Q1 standalone net up 16 per cent - The Hindu BusinessLine thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.
Lincoln Pharmaceuticals Limited board recommends dividend of Rs. 1.50 equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Lincoln Pharmaceuticals Ltd consolidated Q4FY21 net profit at Rs. 12.57 crore equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Lincoln Pharma Q4 standalone net up 30%
May 25, 2021
Net revenues from operations rises to ₹78 crore
Lincoln Pharmaceuticals Limited on Tuesday posted standalone net profit of ₹12 crore for the fourth quarter ended March 31, , against ₹Rs 9 crore in the corresponding quarter a year ago, a 30 per cent jump. Standalone net revenues from operations for the quarter stood at ₹78 crore (₹75 crore). Standalone EBITDA was at ₹17 crore, up 28 per cent compared ₹13 crore in the corresponding period last year.
For the financial year ended March 2021, the company s net profit stood at ₹60 crore (₹50 crore) a jump of 22 per cent year-on-year. Standalone net revenues from operations for the fiscal stood at ₹413 crore (₹376 crore).
Lincoln Pharmaceuticals Ltd Q3FY21 consolidated PAT drops QoQ to Rs. 13.48 crore
Posted On:
LINCOLN PHARMACEUTICALS LTD. has reported financial results for the period ended December 31, 2020.
Financial Results (Q3 FY20-21) - QoQ Comparison
The company has reported total income of Rs.115.47 crores during the period ended December 31, 2020 as compared to Rs.126.66 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.13.48 crores for the period ended December 31, 2020 as against net profit / (loss) of Rs.20.91 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.6.74 for the period ended December 31, 2020 as compared to Rs.10.46 for the period ended September 30, 2020.